Endologix, Inc. (ELGX) Posts Q3 EPS Loss of $0.09, Raises FY11 Sales Guidance
Tweet
Share
E-mailGet Alerts ELGX Hot Sheet
Price: $0.22 --0%
Financial Fact:
Cost of goods sold: 15.19M
Today's EPS Names:
SFST, VLTO, CLIR, More
Financial Fact:
Cost of goods sold: 15.19M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Endologix, Inc. (NASDAQ: ELGX) reported Q3 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $22.3 million versus the consensus estimate of $20.14 million.
Endologix, Inc. sees FY2011 EPS of $-0.30-$-0.25. Endologix, Inc. sees FY2011 revenue of $82-$84 million, versus prior guidance of $79-$82 million.
Endologix, Inc. sees FY2011 EPS of $-0.30-$-0.25. Endologix, Inc. sees FY2011 revenue of $82-$84 million, versus prior guidance of $79-$82 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
- Lockheed Martin (LMT) Tops Q1 EPS by 59c, Beats on Revenue; Offers FY24 Guidance
- Quest Diagnostics (DGX) Tops Q1 EPS by 18c, Beats on Revenue; Offers FY24 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
